A page from a Cowen and Company financial research report dated February 25, 2019, analyzing the U.S. CBD market. The report projects a $16 billion revenue opportunity by 2025, breaking down the market into sectors such as nutraceuticals ($6.4bn), topicals ($4bn), and beverages ($2.4bn). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was produced as part of a Congressional investigation, potentially related to financial records, though no specific Epstein connection is visible in the text of this specific page.
| Name | Role | Context |
|---|---|---|
| Michael Cella | Recipient/Employee |
Email address michael.cella@cowen.com appears in the watermark indicating the report is specifically intended for him.
|
| Name | Type | Context |
|---|---|---|
| Cowen and Company |
Financial services firm that produced the report.
|
|
| U.S. Census |
Cited for population projections.
|
|
| House Oversight Committee |
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024825'.
|
| Location | Context |
|---|---|
|
The market geography being analyzed for CBD revenue.
|
"With growing consumer awareness, we conservatively believe that CBD use can grow to 10% of adults in the U.S., or ~25 mm consumers (using current population) by 2025."Source
"If we assume that the average consumer ultimately spends $640 per year (or less than $2 / day), that would imply a $16 bn market opportunity for CBD."Source
"This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited."Source
Complete text extracted from the document (1,814 characters)
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document